4.4 Article

The Parkinson's Disease-Associated H50Q Mutation Accelerates α-Synuclein Aggregation in Vitro

Journal

BIOCHEMISTRY
Volume 52, Issue 40, Pages 6925-6927

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/bi400999d

Keywords

-

Funding

  1. DBT [BT/PR14344Med/30/501/2010, BT/PR13359/BRB/10/752/2009]
  2. DST [SR/FR/LS-032/2009]
  3. CSIR [37(1404)110/EMR-11]
  4. ICMR, Government of India [5/20/9 (Bio)/11-NCD-I]
  5. Ramalingaswami fellowship

Ask authors/readers for more resources

alpha-Synuclein (alpha-Syn) aggregation is directly linked with Parkinson's disease (PD) pathogenesis. Here, we analyzed the aggregation of newly discovered a-Syn missense mutant H50Q in vitro and found that this mutation significantly accelerates the aggregation and amyloid formation of alpha-Syn. This mutation, however, did not alter the overall secondary structure as suggested by two-dimensional nuclear magnetic resonance and circular dichroism spectroscopy. The initial oligomerization study by cross-linking and chromatographic techniques suggested that this mutant oligomerizes to an extent similar to that of the wild-type alpha-Syn protein. Understanding the aggregation mechanism of this H50Q mutant may help to establish the aggregation and phenotypic relationship of this novel mutant in PD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available